ESMO and Imedex announce partnership for the World Congress on Gastrointestinal Cancer

December 15, 2004

ALPHARETTA, Ga. 15 December 2004 - Imedex, Inc. and The European Society for Medical Oncology (ESMO) today announced their collaboration in the promotion of The World Congress on Gastrointestinal Cancer®, a clinically-focused Congress that has attracted thousands of oncologists and gastroenterologists since its inception in 1999. In a joint statement

  • Paris Kosmidis, MD and President of ESMO,
  • Stefan Terwindt, President of the Congress organizer, Imedex, Inc.,
  • Eric Van Cutsem, MD, PhD, and Mario Dicato, MD, Congress co-chairmen,

    emphasized the benefits of collaboration and dedication to the future success of the Congress.

    "The World Congress on Gastrointestinal Cancer is the most important international meeting on gastrointestinal cancer," Dicato said, "and the endorsement by such a prominent organization as ESMO will certainly raise the exposure of this event internationally."

    "The endorsement of the World Congress on Gastrointestinal Cancer fits into the ongoing mission of ESMO to provide medical oncologists around the world with the information, knowledge, and experience that are the backbones of excellence in clinical practice," said Kosmidis. "The World Congress is leading the way in offering clinically significant information to its growing number of attendees each year. We believe that this Congress plays a significant role in educating and updating medical oncologists working in the field of gastrointestinal cancers and through this collaboration, we can bring a high quality educational experience to a growing network of practicing physicians."

    The World Congress on Gastrointestinal Cancer (www.worldgicancer.com) is entering its 7th year, with the 2005 meeting scheduled for 15-18 June 2005 in Barcelona, Spain. The Congress provides a forum where specialists in cancer research, leading oncologists and practicing clinicians review the state-of-the-art in gastrointestinal cancer and share the latest information on its multidisciplinary management. A total of 86 countries were represented by 2,250 attendees in 2004.
    -end-


    European Society for Medical Oncology

    Related Oncologists Articles from Brightsurf:

    Mayo study identifies barriers to physician adoption of federal Right to Try law
    A new study published in the Journal of the National Cancer Institute is the first to examine the opinions and experiences of clinical oncologists working at a major medical center on the Federal Right to Try (RTT) law.

    COVID-19 pandemic halts cancer care and damages oncologists' wellbeing
    Delays and cancellation of cancer treatments and other safety measures undertaken to minimise the risk of exposure to the coronavirus (COVID-19) have generated a huge backlog in oncology care and research.

    Cancer doctors call for more training in palliative care and delivery of 'bad news'
    Oncologists who practice and teach at the Johns Hopkins Kimmel Cancer Center are calling on medical oncology training programs to invest substantially more time educating physicians about palliative care and how to talk to patients about 'bad news.'

    One in four oncologists fails to mention cost when discussing genomic testing
    Nearly one in four oncologists discussing genomic testing with their patients rarely or never discusses the costs of testing, according to a new study led by American Cancer Society investigators.

    Oncologists respond swiftly to FDA safety alerts, Penn study finds
    Within six months of the U.S. Food and Drug Administration's (FDA) move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.

    Oncologists echo findings that suggest a reduced risk of breast cancer recurrence
    Oncologists at VCU Massey Cancer Center were invited to co-author an editorial published in the Journal of Clinical Oncology providing expert commentary on findings from a large study conducted by German investigators that a modified drug combination may lead to a decreased chance of disease recurrence for women with high risk, HER-2 negative breast cancer.

    ASCO: Oncologists see benefit of medical marijuana, but not comfortable prescribing
    73 percent of oncology providers believe that medical marijuana provides benefits for cancer patients, but only 46 percent are comfortable recommending it.

    Survey questions cancer doctors' awareness of LGBTQ issues
    Most oncologists say they don't know enough about how to treat patients with differences in sexual orientation or identity, but most are also interested in learning more, a new study finds.

    Moffitt leads the nation in addressing LGBTQ health care disparities and education
    Moffitt launched the first nationwide survey to identify potential gaps in attitudes, knowledge and institutional practices for LGBTQ patients.

    Oncologists' LGBT-related knowledge & practices improved after cultural competency training
    An interactive online LGBT cultural competency training program for oncologists may be acceptable, feasible, and improve LGBT-related knowledge and clinical practices.

    Read More: Oncologists News and Oncologists Current Events
  • Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.